Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 385

1.

EVI1 triggers metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase.

Saito Y, Sawa D, Kinoshita M, Yamada A, Kamimura S, Suekane A, Ogoh H, Matsuo H, Adachi S, Taga T, Tomizawa D, Osato M, Soga T, Morishita K, Moritake H.

Haematologica. 2019 Oct 24. pii: haematol.2019.225953. doi: 10.3324/haematol.2019.225953. [Epub ahead of print]

2.

Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.

Shiba N, Yoshida K, Hara Y, Yamato G, Shiraishi Y, Matsuo H, Okuno Y, Chiba K, Tanaka H, Kaburagi T, Takeuchi M, Ohki K, Sanada M, Okubo J, Tomizawa D, Taki T, Shimada A, Sotomatsu M, Horibe K, Taga T, Adachi S, Tawa A, Miyano S, Ogawa S, Hayashi Y.

Blood Adv. 2019 Oct 22;3(20):3157-3169. doi: 10.1182/bloodadvances.2019000404.

PMID:
31648321
3.

Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroup.

Hara Y, Shiba N, Yamato G, Ohki K, Tabuchi K, Sotomatsu M, Tomizawa D, Kinoshita A, Arakawa H, Saito AM, Kiyokawa N, Tawa A, Horibe K, Taga T, Adachi S, Taki T, Hayashi Y.

Br J Haematol. 2019 Oct 14. doi: 10.1111/bjh.16203. [Epub ahead of print]

PMID:
31612466
4.

Highly sensitive detection of GATA1 mutations in patients with myeloid leukemia associated with Down syndrome by combining Sanger and targeted next generation sequencing.

Terui K, Toki T, Taga T, Iwamoto S, Miyamura T, Hasegawa D, Moritake H, Hama A, Nakashima K, Kanezaki R, Kudo K, Saito AM, Horibe K, Adachi S, Tomizawa D, Ito E.

Genes Chromosomes Cancer. 2019 Oct 13. doi: 10.1002/gcc.22816. [Epub ahead of print]

PMID:
31606922
5.

Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.

Labuhn M, Perkins K, Matzk S, Varghese L, Garnett C, Papaemmanuil E, Metzner M, Kennedy A, Amstislavskiy V, Risch T, Bhayadia R, Samulowski D, Hernandez DC, Stoilova B, Iotchkova V, Oppermann U, Scheer C, Yoshida K, Schwarzer A, Taub JW, Crispino JD, Weiss MJ, Hayashi Y, Taga T, Ito E, Ogawa S, Reinhardt D, Yaspo ML, Campbell PJ, Roberts I, Constantinescu SN, Vyas P, Heckl D, Klusmann JH.

Cancer Cell. 2019 Sep 16;36(3):340. doi: 10.1016/j.ccell.2019.08.014. No abstract available.

PMID:
31526763
6.

Characteristics and outcomes of children with acute myeloid leukemia and Down syndrome who are ineligible for clinical trials due to severe comorbidities.

Nakashima K, Hasegawa D, Tomizawa D, Miyamura T, Hama A, Iwamoto S, Terui K, Adachi S, Taga T.

Pediatr Blood Cancer. 2019 Nov;66(11):e27942. doi: 10.1002/pbc.27942. Epub 2019 Aug 18.

PMID:
31423753
7.

Retrospective analysis of children with high-risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML-05 clinical trial.

Hyakuna N, Hashii Y, Ishida H, Umeda K, Takahashi Y, Nagasawa M, Yabe H, Nakazawa Y, Koh K, Goto H, Fujisaki H, Matsumoto K, Kakuda H, Yano M, Tawa A, Tomizawa D, Taga T, Adachi S, Kato K.

Pediatr Blood Cancer. 2019 Oct;66(10):e27875. doi: 10.1002/pbc.27875. Epub 2019 Jul 16.

PMID:
31309713
8.

Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.

Labuhn M, Perkins K, Matzk S, Varghese L, Garnett C, Papaemmanuil E, Metzner M, Kennedy A, Amstislavskiy V, Risch T, Bhayadia R, Samulowski D, Hernandez DC, Stoilova B, Iotchkova V, Oppermann U, Scheer C, Yoshida K, Schwarzer A, Taub JW, Crispino JD, Weiss MJ, Hayashi Y, Taga T, Ito E, Ogawa S, Reinhardt D, Yaspo ML, Campbell PJ, Roberts I, Constantinescu SN, Vyas P, Heckl D, Klusmann JH.

Cancer Cell. 2019 Aug 12;36(2):123-138.e10. doi: 10.1016/j.ccell.2019.06.007. Epub 2019 Jul 11. Erratum in: Cancer Cell. 2019 Sep 16;36(3):340.

PMID:
31303423
9.

Negative CD19 expression is associated with inferior relapse-free survival in children with RUNX1-RUNX1T1-positive acute myeloid leukaemia: results from the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study.

Sakamoto K, Shiba N, Deguchi T, Kiyokawa N, Hashii Y, Moriya-Saito A, Tomizawa D, Taga T, Adachi S, Horibe K, Imamura T.

Br J Haematol. 2019 Nov;187(3):372-376. doi: 10.1111/bjh.16080. Epub 2019 Jun 27.

PMID:
31247675
10.

Registration-directed phase 1/2 trial of irinotecan for pediatric solid tumors.

Makimoto A, Mugishima H, Taga T, Ishida Y, Nagatoshi Y, Ida K, Kumagai M, Kimura T, Ohashi Y, Kaneko M.

Pediatr Int. 2019 May;61(5):453-458. doi: 10.1111/ped.13826. Epub 2019 May 14.

PMID:
30859690
11.

Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study.

Miyamura T, Moritake H, Nakayama H, Tanaka S, Tomizawa D, Shiba N, Saito AM, Tawa A, Shimada A, Iwamoto S, Hayashi Y, Koike T, Horibe K, Manabe A, Mizutani S, Taga T, Adachi S.

Br J Haematol. 2019 Apr;185(2):284-288. doi: 10.1111/bjh.15799. Epub 2019 Feb 19.

PMID:
30784060
12.

Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemia.

Okamoto Y, Kudo K, Tabuchi K, Tomizawa D, Taga T, Goto H, Yabe H, Nakazawa Y, Koh K, Ikegame K, Yoshida N, Uchida N, Watanabe K, Koga Y, Inoue M, Kato K, Atsuta Y, Ishida H.

Bone Marrow Transplant. 2019 Sep;54(9):1489-1498. doi: 10.1038/s41409-019-0461-0. Epub 2019 Feb 4.

PMID:
30718800
13.

Sepsis in a 4-Month-Old Boy Due to Carbapenem-Resistant Enterobacteriaceae Characterized by AmpC β-Lactamase with Porin Loss.

Shimizu J, Taga T, Sato T, Eguchi Y.

Int J Appl Basic Med Res. 2018 Oct-Dec;8(4):263-265. doi: 10.4103/ijabmr.IJABMR_383_17.

14.

A proposed new rotating reference axis for the tibial component after proximal tibial resection in total knee arthroplasty.

Ohmori T, Kabata T, Kajino Y, Inoue D, Taga T, Yamamoto T, Takagi T, Yoshitani J, Ueno T, Ueoka K, Tsuchiya H.

PLoS One. 2018 Dec 20;13(12):e0209317. doi: 10.1371/journal.pone.0209317. eCollection 2018.

15.

The optimal combined anteversion pattern to achieve a favorable impingement-free angle in total hip arthroplasty.

Ohmori T, Kabata T, Kajino Y, Inoue D, Taga T, Yamamoto T, Takagi T, Yoshitani J, Ueno T, Ueoka K, Tsuchiya H.

J Orthop Sci. 2019 May;24(3):474-481. doi: 10.1016/j.jos.2018.11.008. Epub 2018 Dec 13.

PMID:
30554937
16.

Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia.

Matsuo H, Yoshida K, Fukumura K, Nakatani K, Noguchi Y, Takasaki S, Noura M, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Okada A, Nannya Y, Takeda J, Ueno H, Shiba N, Yamato G, Handa H, Ono Y, Hiramoto N, Ishikawa T, Usuki K, Ishiyama K, Miyawaki S, Itonaga H, Miyazaki Y, Kawamura M, Yamaguchi H, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Hayashi Y, Mano H, Miyano S, Kamikubo Y, Ogawa S, Adachi S.

Blood Adv. 2018 Nov 13;2(21):2879-2889. doi: 10.1182/bloodadvances.2018019398.

17.

Effect of changing femoral head diameter on bony and prosthetic jumping angles.

Ohmori T, Kabata T, Kajino Y, Inoue D, Taga T, Yamamoto T, Takagi T, Yoshitani J, Ueno T, Ueoka K, Tsuchiya H.

Eur J Orthop Surg Traumatol. 2019 Apr;29(3):625-632. doi: 10.1007/s00590-018-2325-5. Epub 2018 Oct 30.

PMID:
30377824
18.

Clinical characteristics of pediatric patients with myeloid sarcoma without bone marrow involvement in Japan.

Taga T, Imamura T, Nakashima K, Maeda N, Watanabe A, Miyajima Y, Sakaguchi S, Sano H, Hasegawa D, Kawasaki H, Adachi S, Takagi M, Koh K, Manabe A, Taki T, Ishida Y.

Int J Hematol. 2018 Oct;108(4):438-442. doi: 10.1007/s12185-018-2492-5. Epub 2018 Jul 3.

PMID:
29971602
19.

Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases.

Tomizawa D, Yoshida M, Kondo T, Miyamura T, Taga T, Adachi S, Koh K, Noguchi M, Kakuda H, Watanabe K, Cho Y, Fukuda T, Kato M, Shiba N, Goto H, Okada K, Inoue M, Hashii Y, Atsuta Y, Ishida H.

Bone Marrow Transplant. 2019 Mar;54(3):393-401. doi: 10.1038/s41409-018-0273-7. Epub 2018 Jun 29.

PMID:
29959436
20.

Whole-exome analysis to detect congenital hemolytic anemia mimicking congenital dyserythropoietic anemia.

Hamada M, Doisaki S, Okuno Y, Muramatsu H, Hama A, Kawashima N, Narita A, Nishio N, Yoshida K, Kanno H, Manabe A, Taga T, Takahashi Y, Miyano S, Ogawa S, Kojima S.

Int J Hematol. 2018 Sep;108(3):306-311. doi: 10.1007/s12185-018-2482-7. Epub 2018 Jun 23.

PMID:
29936674
21.

Evaluation of high-dose cytarabine in induction therapy for children with de novo acute myeloid leukemia: a study protocol of the Japan Children's Cancer Group Multi-Center Seamless Phase II-III Randomized Trial (JPLSG AML-12).

Tomizawa D, Tanaka S, Hasegawa D, Iwamoto S, Hiramatsu H, Kiyokawa N, Miyachi H, Horibe K, Saito AM, Taga T, Adachi S.

Jpn J Clin Oncol. 2018 Jun 1;48(6):587-593. doi: 10.1093/jjco/hyy061.

PMID:
29889285
22.

Clinical Results of Total Hip Arthroplasty in Two Patients with Charcot Hip Joints due to Congenital Insensivity to Pain with Anhydrosis.

Inoue D, Kabata T, Kajino Y, Taga T, Yamamoto T, Takagi T, Ohmori T, Tsuchiya H.

Case Rep Orthop. 2018 Jan 31;2018:1743068. doi: 10.1155/2018/1743068. eCollection 2018.

23.

Nationwide survey of therapy-related leukemia in childhood in Japan.

Imamura T, Taga T, Takagi M, Kawasaki H, Koh K, Taki T, Adachi S, Manabe A, Ishida Y; Leukemia/Lymphoma Committee; Japanese Society of Pediatric Hematology Oncology (JSPHO).

Int J Hematol. 2018 Jul;108(1):91-97. doi: 10.1007/s12185-018-2439-x. Epub 2018 Mar 24.

PMID:
29574603
24.

RUNX1 mutations in pediatric acute myeloid leukemia are associated with distinct genetic features and an inferior prognosis.

Yamato G, Shiba N, Yoshida K, Hara Y, Shiraishi Y, Ohki K, Okubo J, Park MJ, Sotomatsu M, Arakawa H, Kiyokawa N, Tomizawa D, Adachi S, Taga T, Horibe K, Miyano S, Ogawa S, Hayashi Y.

Blood. 2018 May 17;131(20):2266-2270. doi: 10.1182/blood-2017-11-814442. Epub 2018 Mar 14. No abstract available.

PMID:
29540347
25.

Maintenance of hematopoietic stem and progenitor cells in fetal intra-aortic hematopoietic clusters by the Sox17-Notch1-Hes1 axis.

Saito K, Nobuhisa I, Harada K, Takahashi S, Anani M, Lickert H, Kanai-Azuma M, Kanai Y, Taga T.

Exp Cell Res. 2018 Apr 1;365(1):145-155. doi: 10.1016/j.yexcr.2018.02.014. Epub 2018 Feb 16.

PMID:
29458175
26.

Comparison with the osteoconductivity and bone-bonding ability of the iodine supported titanium, titanium with porous oxide layer and the titanium alloy in the rabbit model.

Taga T, Kabata T, Kajino Y, Inoue D, Ohmori T, Yamamoto T, Takagi T, Tsuchiya H.

J Orthop Sci. 2018 May;23(3):585-591. doi: 10.1016/j.jos.2018.01.007. Epub 2018 Feb 9.

PMID:
29429889
27.

Three-dimensional limb lengthening after total knee arthroplasty in a simulation study.

Ohmori T, Kabata T, Kajino Y, Inoue D, Taga T, Yamamoto T, Takagi T, Yoshitani J, Ueno T, Ueoka K, Tsuchiya H.

Mod Rheumatol. 2018 Nov;28(6):1029-1034. doi: 10.1080/14397595.2018.1436119. Epub 2018 Feb 20.

PMID:
29385865
28.

Usefulness of the "grand-piano sign" for determining femoral rotational alignment in total knee arthroplasty.

Ohmori T, Kabata T, Kajino Y, Taga T, Inoue D, Yamamoto T, Takagi T, Yoshitani J, Ueno T, Tsuchiya H.

Knee. 2018 Jan;25(1):15-24. doi: 10.1016/j.knee.2017.11.008. Epub 2018 Jan 12.

PMID:
29338974
29.

Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study.

Shimada A, Iijima-Yamashita Y, Tawa A, Tomizawa D, Yamada M, Norio S, Watanabe T, Taga T, Iwamoto S, Terui K, Moritake H, Kinoshita A, Takahashi H, Nakayama H, Koh K, Goto H, Kosaka Y, Saito AM, Kiyokawa N, Horibe K, Hara Y, Oki K, Hayashi Y, Tanaka S, Adachi S.

Int J Hematol. 2018 May;107(5):586-595. doi: 10.1007/s12185-017-2395-x. Epub 2018 Jan 12.

PMID:
29330746
30.

Purpura fulminans in congenital protein C deficiency successfully treated with fresh frozen plasma and thrombomodulin.

Hayami T, Yamaguchi A, Kato T, Tanaka T, Nishizawa Y, Yanagi T, Taga T, Matsumoto S, Uchiumi T, Fujimoto N.

J Dermatol. 2018 Jun;45(6):e165-e166. doi: 10.1111/1346-8138.14194. Epub 2017 Dec 19. No abstract available.

PMID:
29265490
31.

Gfap and Osmr regulation by BRG1 and STAT3 via interchromosomal gene clustering in astrocytes.

Ito K, Noguchi A, Uosaki Y, Taga T, Arakawa H, Takizawa T.

Mol Biol Cell. 2018 Jan 15;29(2):209-219. doi: 10.1091/mbc.E17-05-0271. Epub 2017 Nov 15.

32.

Multiplex fusion gene testing in pediatric acute myeloid leukemia.

Iijima-Yamashita Y, Matsuo H, Yamada M, Deguchi T, Kiyokawa N, Shimada A, Tawa A, Takahashi H, Tomizawa D, Taga T, Kinoshita A, Adachi S, Horibe K.

Pediatr Int. 2018 Jan;60(1):47-51. doi: 10.1111/ped.13451.

PMID:
29105243
33.

Monitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia.

Matsuo H, Iijima-Yamashita Y, Yamada M, Deguchi T, Kiyokawa N, Shimada A, Tawa A, Tomizawa D, Taga T, Kinoshita A, Adachi S, Horibe K.

Pediatr Int. 2018 Jan;60(1):41-46. doi: 10.1111/ped.13440.

PMID:
29067751
34.

Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia.

Kuwatsuka Y, Tomizawa D, Kihara R, Nagata Y, Shiba N, Iijima-Yamashita Y, Shimada A, Deguchi T, Miyachi H, Tawa A, Taga T, Kinoshita A, Nakayama H, Kiyokawa N, Saito AM, Koh K, Goto H, Kosaka Y, Asou N, Ohtake S, Miyawaki S, Miyazaki Y, Sakura T, Ozawa Y, Usui N, Kanamori H, Ito Y, Imai K, Suehiro Y, Kobayashi S, Kitamura K, Sakaida E, Ogawa S, Naoe T, Hayashi Y, Horibe K, Manabe A, Mizutani S, Adachi S, Kiyoi H.

Int J Hematol. 2018 Feb;107(2):201-210. doi: 10.1007/s12185-017-2340-z. Epub 2017 Oct 12.

PMID:
29027108
35.

Differences in range of motion with the same combined anteversion after total hip arthroplasty.

Ohmori T, Kabata T, Kajino Y, Taga T, Hasegawa K, Inoue D, Yamamoto T, Takagi T, Yoshitani J, Ueno T, Tsuchiya H.

Int Orthop. 2018 May;42(5):1021-1028. doi: 10.1007/s00264-017-3653-5. Epub 2017 Oct 9.

PMID:
28990125
36.

The accuracy of the "projected surgical transepicondylar axis" relative to the "true surgical transepicondylar axis" in total knee arthroplasty.

Ohmori T, Kabata T, Kajino Y, Taga T, Hasegawa K, Inoue D, Yamamoto T, Takagi T, Yoshitani J, Ueno T, Ojima T, Tsuchiya H.

Knee. 2017 Dec;24(6):1428-1434. doi: 10.1016/j.knee.2017.07.017. Epub 2017 Oct 1.

PMID:
28978461
37.

Fludarabine, cytarabine, granulocyte colony-stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia.

Nakayama H, Tomizawa D, Tanaka S, Iwamoto S, Shimada A, Saito AM, Yamashita Y, Moritake H, Terui K, Taga T, Matsuo H, Kosaka Y, Koh K, Hosoi H, Kurosawa H, Isoyama K, Horibe K, Mizutani S, Adachi S.

Pediatr Int. 2017 Oct;59(10):1046-1052. doi: 10.1111/ped.13378.

PMID:
28771903
38.

Allogeneic Hematopoietic Stem Cell Transplantation for Adolescents and Young Adults with Acute Myeloid Leukemia.

Tomizawa D, Tanaka S, Kondo T, Hashii Y, Arai Y, Kudo K, Taga T, Fukuda T, Goto H, Inagaki J, Koh K, Ohashi K, Ozawa Y, Inoue M, Kato K, Tanaka J, Atsuta Y, Adachi S, Ishida H.

Biol Blood Marrow Transplant. 2017 Sep;23(9):1515-1522. doi: 10.1016/j.bbmt.2017.05.009. Epub 2017 May 10.

39.

The influence of surgical approach on postoperative pelvic tilt after total hip arthroplasty.

Inoue D, Kabata T, Kajino Y, Taga T, Hasegawa K, Yamamoto T, Takagi T, Ohmori T, Tsuchiya H.

Eur J Orthop Surg Traumatol. 2017 Dec;27(8):1131-1138. doi: 10.1007/s00590-017-1946-4. Epub 2017 Mar 21.

PMID:
28324202
40.

Thrombopoietin contributes to the formation and the maintenance of hematopoietic progenitor-containing cell clusters in the aorta-gonad-mesonephros region.

Harada K, Nobuhisa I, Anani M, Saito K, Taga T.

Cytokine. 2017 Jul;95:35-42. doi: 10.1016/j.cyto.2017.02.012. Epub 2017 Feb 21.

PMID:
28235674
41.

Outcome of relapsed core binding factor acute myeloid leukemia in children: A result from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05R study.

Moritake H, Tanaka S, Nakayama H, Miyamura T, Iwamoto S, Shimada A, Terui K, Saito A, Shiba N, Hayashi Y, Tomizawa D, Taga T, Goto H, Hasegawa D, Horibe K, Mizutani S, Adachi S.

Pediatr Blood Cancer. 2017 Oct;64(10). doi: 10.1002/pbc.26491. Epub 2017 Feb 24. No abstract available.

PMID:
28233452
42.

Genomic profiling of Acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis.

Ratnaparkhe M, Hlevnjak M, Kolb T, Jauch A, Maass KK, Devens F, Rode A, Hovestadt V, Korshunov A, Pastorczak A, Mlynarski W, Sungalee S, Korbel J, Hoell J, Fischer U, Milde T, Kramm C, Nathrath M, Chrzanowska K, Tausch E, Takagi M, Taga T, Constantini S, Loeffen J, Meijerink J, Zielen S, Gohring G, Schlegelberger B, Maass E, Siebert R, Kunz J, Kulozik AE, Worst B, Jones DT, Pfister SM, Zapatka M, Lichter P, Ernst A.

Leukemia. 2017 Oct;31(10):2048-2056. doi: 10.1038/leu.2017.55. Epub 2017 Feb 15.

PMID:
28196983
43.

Enhancement of 5-aminolevulinic acid-based fluorescence detection of side population-defined glioma stem cells by iron chelation.

Wang W, Tabu K, Hagiya Y, Sugiyama Y, Kokubu Y, Murota Y, Ogura SI, Taga T.

Sci Rep. 2017 Feb 7;7:42070. doi: 10.1038/srep42070.

44.

Increase in safe zone area of the acetabular cup using dual mobility cups in THA.

Ohmori T, Kabata T, Maeda T, Kajino Y, Taga T, Hasegawa K, Inoue D, Yamamoto T, Takagi T, Tsuchiya H.

Hip Int. 2017 Jul 25;27(4):361-367. doi: 10.5301/hipint.5000466. Epub 2017 Jan 31.

PMID:
28165597
45.

Selection of a surgical approach for total hip arthroplasty according to the depth to the surgical site.

Ohmori T, Kabata T, Maeda T, Kajino Y, Taga T, Hasegawa K, Inoue D, Yamamoto T, Takagi T, Tsuchiya H.

Hip Int. 2017 May 12;27(3):273-280. doi: 10.5301/hipint.5000463. Epub 2017 Feb 4.

PMID:
28165592
46.

ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosis.

Yamato G, Shiba N, Yoshida K, Shiraishi Y, Hara Y, Ohki K, Okubo J, Okuno H, Chiba K, Tanaka H, Kinoshita A, Moritake H, Kiyokawa N, Tomizawa D, Park MJ, Sotomatsu M, Taga T, Adachi S, Tawa A, Horibe K, Arakawa H, Miyano S, Ogawa S, Hayashi Y.

Genes Chromosomes Cancer. 2017 May;56(5):382-393. doi: 10.1002/gcc.22443. Epub 2017 Feb 14.

PMID:
28063196
47.

Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.

Hara Y, Shiba N, Ohki K, Tabuchi K, Yamato G, Park MJ, Tomizawa D, Kinoshita A, Shimada A, Arakawa H, Saito AM, Kiyokawa N, Tawa A, Horibe K, Taga T, Adachi S, Taki T, Hayashi Y.

Genes Chromosomes Cancer. 2017 May;56(5):394-404. doi: 10.1002/gcc.22444. Epub 2017 Feb 14.

PMID:
28063190
48.

Acute lymphoblastic leukemia in patients with Down syndrome with a previous history of acute myeloid leukemia.

Tomizawa D, Endo A, Kajiwara M, Sakaguchi H, Matsumoto K, Kaneda M, Taga T.

Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26411. Epub 2016 Dec 24.

PMID:
28012245
50.

Exophytic Tumor Growth After Incomplete Removal of Polypoid Malignant Melanoma of the Maxillary Gingiva: A Case Report and Review of the Literature.

Taga T, Nonaka T, Manabe T, Bessho K.

J Oral Maxillofac Surg. 2016 Nov;74(11):2328.e1-2328.e8. doi: 10.1016/j.joms.2016.07.018. Epub 2016 Jul 30. Review.

PMID:
27566460

Supplemental Content

Support Center